MicroRNA Signature and Regulatory Functions in the Endometrium during Normal and Disease States

 

 Buy Article Permissions and Reprints

ABSTRACT

During the menstrual cycle, human endometrium undergoes extensive cyclic morphologic and biochemical modifications in preparation for embryo implantation. These processes are highly regulated by ovarian steroids and various locally expressed gene products and involve inflammatory reaction, apoptosis, cell proliferation, angiogenesis, differentiation (tissue formation), and tissue remodeling. MicroRNAs (miRNAs) have emerged as key regulators of gene expression, and their altered and/or aberrant expression has been associated with establishment and progression of various disorders, including tumorigenesis. This review highlights the endometrial expression of miRNAs and their potential regulatory functions under normal and pathologic conditions such as endometriosis, dysfunctional uterine bleeding, and endometrial cancer. Given the key regulatory function of miRNAs on gene expression stability, understanding the underlying mechanisms of how endometrial miRNAs are regulated and identifying their specific target genes and their functions might lead to the development of preventive and therapeutic strategies by regulating specific target genes associated with such reproductive disorders.

REFERENCES

• 1 Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation.  Hum Reprod Update. 2006;  12 731-746
  CrossrefPubMedGoogle Scholar
• 2 Chegini N, Williams R S. Cytokine networks in human endometrium from menstruation to implantation. In: Hill J Cytokines in Human Reproduction. Hoboken, NJ; John Wiley & Sons 2000: 93-132
  Google Scholar
• 3 Du H, Taylor H S. Contribution of bone marrow-derived stem cells to endometrium and endometriosis.  Stem Cells. 2007;  25 2082-2086
  CrossrefPubMedGoogle Scholar
• 4 Girling J E, Rogers P A. Recent advances in endometrial angiogenesis research.  Angiogenesis. 2005;  8 89-99
  CrossrefPubMedGoogle Scholar
• 5 Horcajadas J A, Pellicer A, Simon C. Wide genomic analysis of human endometrial receptivity: new times, new opportunities.  Hum Reprod Update. 2007;  13 77-86
  CrossrefPubMedGoogle Scholar
• 6 Jabbour H N, Kelly R W, Fraser H M et al.. Endocrine regulation of menstruation.  Endocr Rev. 2006;  27 17-46
  CrossrefPubMedGoogle Scholar
• 7 Makker A, Singh M M. Endometrial receptivity: clinical assessment in relation to fertility, infertility, and antifertility.  Med Res Rev. 2006;  26 699-746
  CrossrefPubMedGoogle Scholar
• 8 Ferenczy A. Pathophysiology of endometrial bleeding.  Maturitas. 2003;  45 1-14
  CrossrefPubMedGoogle Scholar
• 9 Harada T, Taniguchi F, Izawa M et al.. Apoptosis and endometriosis.  Front Biosci. 2007;  12 3140-3151
  CrossrefPubMedGoogle Scholar
• 10 Abal M, Planaguma J, Gil-Moreno A et al.. Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.  Histol Histopathol. 2006;  21 197-204
  PubMedGoogle Scholar
• 11 Prat J, Gallardo A, Cuatrecasas M et al.. Endometrial carcinoma: pathology and genetics.  Pathology. 2007;  39 72-87
  CrossrefPubMedGoogle Scholar
• 12 Ambros V, Chen X. The regulation of genes and genomes by small RNAs.  Development. 2007;  134 1635-1641
  CrossrefPubMedGoogle Scholar
• 13 Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function.  Cell. 2004;  116 281-297
  CrossrefPubMedGoogle Scholar
• 14 Bernstein E, Caudy A A, Hammond S M et al.. Role for a bidentate ribonuclease in the initiation step of RNA interference.  Nature. 2001;  409 363-366
  CrossrefPubMedGoogle Scholar
• 15 Paroo Z, Liu Q, Wang X. Biochemical mechanisms of the RNA-induced silencing complex.  Cell Res. 2007;  17 187-194
  PubMedGoogle Scholar
• 16 Bernstein E, Kim S Y, Carmell M A et al.. Dicer is essential for mouse development.  Nat Genet. 2003;  35 215-217
  CrossrefPubMedGoogle Scholar
• 17 Zamore P D, Haley B. Ribo-gnome: the big world of small RNAs.  Science. 2005;  309 1519-1524
  CrossrefPubMedGoogle Scholar
• 18 Jackson R J, Standart N. How do microRNAs regulate gene expression?.  Sci STKE. 2007;  , 2007rel
  PubMedGoogle Scholar
• 19 Nilsen T W. Mechanisms of microRNA-mediated gene regulation in animal cells.  Trends Genet. 2007;  23 243-249
  CrossrefPubMedGoogle Scholar
• 20 Pillai R S, Bhattacharyya S N, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?.  Trends Cell Biol. 2007;  17 118-126
  CrossrefPubMedGoogle Scholar
• 21 Berezikov E, van Tetering G, Verheul M et al.. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis.  Genome Res. 2006;  16 1289-1298
  CrossrefPubMedGoogle Scholar
• 22 Yu Z, Jian Z, Shen S H et al.. Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos.  Nucleic Acids Res. 2007;  35 152-164
  PubMedGoogle Scholar
• 23 Brennecke J, Stark A, Russell R B et al.. Principles of microRNA-target recognition.  PLoS Biol. 2005;  3 e85
  CrossrefPubMedGoogle Scholar
• 24 Grimson A, Farh K K, Johnston W K et al.. MicroRNA targeting specificity in mammals: determinants beyond seed pairing.  Mol Cell. 2007;  27 91-105
  CrossrefPubMedGoogle Scholar
• 25 Lai E C. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation.  Nat Genet. 2002;  30 363-364
  PubMedGoogle Scholar
• 26 Ghosh D, De P, Sengupta J. Luteal phase ovarian oestrogen is not essential for implantation and maintenance of pregnancy from surrogate embryo transfer in the rhesus monkey.  Hum Reprod. 1994;  9 629-637
  PubMedGoogle Scholar
• 27 Smitz J, Bourgain C, Van Waesberghe L et al.. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation.  Hum Reprod. 1993;  8 40-45
  PubMedGoogle Scholar
• 28 Groothuis P G, Dassen H H, Romano A et al.. Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human.  Hum Reprod Update. 2007;  13 405-417
  CrossrefPubMedGoogle Scholar
• 29 Smith O P, Critchley H O. Progestogen only contraception and endometrial break through bleeding.  Angiogenesis. 2005;  8 117-126
  CrossrefPubMedGoogle Scholar
• 30 Smith O P, Jabbour H N, Critchley H O. Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.  Hum Reprod. 2007;  22 1450-1456
  CrossrefPubMedGoogle Scholar
• 31 Kao L C, Tulac S, Lobo S et al.. Global gene profiling in human endometrium during the window of implantation.  Endocrinology. 2002;  143 2119-2138
  CrossrefPubMedGoogle Scholar
• 32 Lee K, Jeong J, Tsai M J et al.. Molecular mechanisms involved in progesterone receptor regulation of uterine function.  J Steroid Biochem Mol Biol. 2006;  102 41-50
  CrossrefPubMedGoogle Scholar
• 33 Sherwin R, Catalano R, Sharkey A. Large-scale gene expression studies of the endometrium: what have we learnt?.  Reproduction. 2006;  132 1-10
  CrossrefPubMedGoogle Scholar
• 34 Taylor R N, Mueller M D. Anti-angiogenic treatment of endometriosis: biochemical aspects.  Gynecol Obstet Invest. 2004;  57 54-56
  PubMedGoogle Scholar
• 35 Chegini N, Ma C, Roberts M et al.. Differential expression of interleukins (IL) IL-13 and IL-15 throughout the menstrual cycle in endometrium of normal fertile women and women with recurrent spontaneous abortion.  J Reprod Immunol. 2002;  56 93-110
  CrossrefPubMedGoogle Scholar
• 36 Chegini N, Roberts M, Ripps B. Differential expression of interleukins (IL)-13 and IL-15 in ectopic and eutopic endometrium of women with endometriosis and normal fertile women.  Am J Reprod Immunol. 2003;  49 75-83
  CrossrefPubMedGoogle Scholar
• 37 Fujimoto J, Toyoki H, Jahan I et al.. Sex steroid-dependent angiogenesis in uterine endometrial cancers.  J Steroid Biochem Mol Biol. 2005;  93 161-165
  CrossrefPubMedGoogle Scholar
• 38 Hannan N J, Salamonsen L A. Role of chemokines in the endometrium and in embryo implantation.  Curr Opin Obstet Gynecol. 2007;  19 266-272
  CrossrefPubMedGoogle Scholar
• 39 Vitiello D, Kodaman P H, Taylor H S. HOX genes in implantation.  Semin Reprod Med. 2007;  25 431-436
  Article in Thieme ConnectPubMedGoogle Scholar
• 40 Pan Q, Luo X, Toloubeydokhti T et al.. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression.  Mol Hum Reprod. 2007;  13 797-806
  CrossrefPubMedGoogle Scholar
• 41 Ambros V. The functions of animal microRNAs.  Nature. 2004;  431 350-355
  CrossrefPubMedGoogle Scholar
• 42 Li S C, Tang P, Lin W C. Intronic microRNA: discovery and biological implications.  DNA Cell Biol. 2007;  26 195-207
  CrossrefPubMedGoogle Scholar
• 43 Lim L P, Lau N C, Garrett-Engele P et al.. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.  Nature. 2005;  433 769-773
  CrossrefPubMedGoogle Scholar
• 44 Carleton M, Cleary M A, Linsley P S. MicroRNAs and cell cycle regulation.  Cell Cycle. 2007;  6 2127-2132
  PubMedGoogle Scholar
• 45 Harfe B D, McManus M T, Mansfield J H et al.. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb.  Proc Natl Acad Sci U S A. 2005;  102 10898-10903
  CrossrefPubMedGoogle Scholar
• 46 Jovanovic M, Hengartner M O. miRNAs and apoptosis: RNAs to die for.  Oncogene. 2006;  25 6176-6187
  CrossrefPubMedGoogle Scholar
• 47 Kuehbacher A, Urbich C, Dimmeler S. Targeting microRNA expression to regulate angiogenesis.  Trends Pharmacol Sci. 2008;  29 12-15
  CrossrefPubMedGoogle Scholar
• 48 Linsley P S, Schelter J, Burchard J et al.. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression.  Mol Cell Biol. 2007;  27 2240-2252
  CrossrefPubMedGoogle Scholar
• 49 Chegini N. Peritoneal molecular environment, adhesion formation and clinical implication.  Front Biosci. 2002;  7 E91-E115
  CrossrefPubMedGoogle Scholar
• 50 Meng F, Henson R, Wehbe-Janek H et al.. The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes.  J Biol Chem. 2007;  282 8256-8264
  CrossrefPubMedGoogle Scholar
• 51 Meng F, Wehbe-Janek H, Henson R et al.. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.  Oncogene. 2008;  27 378-386
  CrossrefPubMedGoogle Scholar
• 52 O'Connell R M, Taganov K D, Boldin M P et al.. MicroRNA-155 is induced during the macrophage inflammatory response.  Proc Natl Acad Sci U S A. 2007;  104 1604-1609
  CrossrefPubMedGoogle Scholar
• 53 Tili E, Michaille J J, Cimino A et al.. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.  J Immunol. 2007;  179 5082-5089
  CrossrefPubMedGoogle Scholar
• 54 Rodriguez A, Vigorito E, Clare S et al.. Requirement of bic/microRNA-155 for normal immune function.  Science. 2007;  316 608-611
  CrossrefPubMedGoogle Scholar
• 55 Costinean S, Zanesi N, Pekarsky Y et al.. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.  Proc Natl Acad Sci U S A. 2006;  103 7024-7029
  CrossrefPubMedGoogle Scholar
• 56 Bergqvist A, Bruse C, Carlberg M et al.. Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium.  Fertil Steril. 2001;  75 489-495
  CrossrefPubMedGoogle Scholar
• 57 Cao W G, Morin M, Sengers V et al.. Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.  Hum Reprod. 2006;  21 421-428
  PubMedGoogle Scholar
• 58 Chegini N, Dou Q, Williams R S. An inverse relation between the expression of tumor necrosis factor alpha (TNF-alpha) and TNF-alpha receptor in human endometrium.  Am J Reprod Immunol. 1999;  42 297-302
  PubMedGoogle Scholar
• 59 Cork B A, Tuckerman E M, Li T C et al.. Expression of interleukin (IL)-11 receptor by the human endometrium in vivo and effects of IL-11, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro.  Mol Hum Reprod. 2002;  8 841-848
  CrossrefPubMedGoogle Scholar
• 60 Kayisli U A, Aksu C A, Berkkanoglu M et al.. Estrogenicity of isoflavones on human endometrial stromal and glandular cells.  J Clin Endocrinol Metab. 2002;  87 5539-5544
  CrossrefPubMedGoogle Scholar
• 61 Khan K N, Masuzaki H, Fujishita A et al.. Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis.  Hum Reprod. 2005;  20 2715-2723
  CrossrefPubMedGoogle Scholar
• 62 Taganov K D, Boldin M P, Baltimore D. MicroRNAs and immunity: tiny players in a big field.  Immunity. 2007;  26 133-137
  CrossrefPubMedGoogle Scholar
• 63 Neilson J R, Zheng G X, Burge C B et al.. Dynamic regulation of miRNA expression in ordered stages of cellular development.  Genes Dev. 2007;  21 578-589
  CrossrefPubMedGoogle Scholar
• 64 Chegini N, Luo X, Pan Q et al.. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.  Hum Reprod. 2007;  22 427-433
  PubMedGoogle Scholar
• 65 Li R, Luo X, Pan Q et al.. Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding.  Hum Reprod. 2006;  21 2555-2563
  CrossrefPubMedGoogle Scholar
• 66 Li R, Luo X, Archer D F et al.. Doxycycline alters the expression of matrix metalloproteases in the endometrial cells exposed to ovarian steroids and pro-inflammatory cytokine.  J Reprod Immunol. 2007;  73 118-129
  CrossrefPubMedGoogle Scholar
• 67 Rhoton-Vlasak A, Chegini N, Hardt N et al.. Histological characteristics and altered expression of interleukins (IL) IL-13 and IL-15 in endometria of levonorgestrel users with different uterine bleeding patterns.  Fertil Steril. 2005;  83 659-665
  CrossrefPubMedGoogle Scholar
• 68 Clark I M, Swingler T E, Sampieri C L et al.. The regulation of matrix metalloproteinases and their inhibitors.  Int J Biochem Cell Biol. 2008;  40 1362-1378
  CrossrefPubMedGoogle Scholar
• 69 Gill S E, Parks W C. Metalloproteinases and their inhibitors: regulators of wound healing.  Int J Biochem Cell Biol. 2008;  40 1334-1347
  CrossrefPubMedGoogle Scholar
• 70 Goffin F, Munaut C, Frankenne F et al.. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.  Biol Reprod. 2003;  69 976-984
  CrossrefPubMedGoogle Scholar
• 71 Dalmay T, Edwards D R. MicroRNAs and the hallmarks of cancer.  Oncogene. 2006;  25 6170-6175
  CrossrefPubMedGoogle Scholar
• 72 Fontana L, Pelosi E, Greco P et al.. MicroRNAs 17–5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation.  Nat Cell Biol. 2007;  9 775-787
  CrossrefPubMedGoogle Scholar
• 73 Li Q J, Chau J, Ebert P J et al.. miR-181a is an intrinsic modulator of T cell sensitivity and selection.  Cell. 2007;  129 147-161
  CrossrefPubMedGoogle Scholar
• 74 Brosens J J, Gellersen B. Death or survival—progesterone-dependent cell fate decisions in the human endometrial stroma.  J Mol Endocrinol. 2006;  36 389-398
  CrossrefPubMedGoogle Scholar
• 75 Meng F, Henson R, Lang M et al.. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.  Gastroenterology. 2006;  130 2113-2129
  Google Scholar
• 76 Si M L, Zhu S, Wu H et al.. miR-21-mediated tumor growth.  Oncogene. 2007;  26 2799-2803
  CrossrefPubMedGoogle Scholar
• 77 Matsubara H, Takeuchi T, Nishikawa E et al.. Apoptosis induction by antisense oligonucleotides against miR-17–5p and miR-20a in lung cancers overexpressing miR-17–92.  Oncogene. 2007;  26 6099-6105
  CrossrefPubMedGoogle Scholar
• 78 Mertens-Talcott S U, Chintharlapalli S, Li X et al.. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.  Cancer Res. 2007;  67 11001-11011
  CrossrefPubMedGoogle Scholar
• 79 Ovcharenko D, Kelnar K, Johnson C et al.. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.  Cancer Res. 2007;  67 10782-10788
  CrossrefPubMedGoogle Scholar
• 80 Garofalo M, Quintavalle C, Di Leva G et al.. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.  Oncogene. 2008;  27 3845-3855
  CrossrefPubMedGoogle Scholar
• 81 Jones R K, Searle R F, Bulmer J N. Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis.  Hum Reprod. 1998;  13 3496-3502
  CrossrefPubMedGoogle Scholar
• 82 Selam B, Kayisli U A, Mulayim N et al.. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium.  Biol Reprod. 2001;  65 979-985
  CrossrefPubMedGoogle Scholar
• 83 Watanabe H, Kanzaki H, Narukawa S et al.. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis.  Am J Obstet Gynecol. 1997;  176 360-368
  CrossrefPubMedGoogle Scholar
• 84 Meng F, Henson R, Wehbe-Janek H et al.. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.  Gastroenterology. 2007;  133 647-658
  CrossrefPubMedGoogle Scholar
• 85 He X, He L, Hannon G J. The guardian's little helper: microRNAs in the p53 tumor suppressor network.  Cancer Res. 2007;  67 11099-11101
  CrossrefPubMedGoogle Scholar
• 86 He L, He X, Lowe S W et al.. microRNAs join the p53 network—another piece in the tumour-suppression puzzle.  Nat Rev Cancer. 2007;  7 819-822
  CrossrefPubMedGoogle Scholar
• 87 Raver-Shapira N, Marciano E, Meiri E et al.. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.  Mol Cell. 2007;  26 731-743
  CrossrefPubMedGoogle Scholar
• 88 Sylvestre Y, De G, Querido E et al.. An E2F/miR-20a autoregulatory feedback loop.  J Biol Chem. 2007;  282 2135-2143
  PubMedGoogle Scholar
• 89 Welch C, Chen Y, Stallings R L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.  Oncogene. 2007;  26 5017-5022
  CrossrefPubMedGoogle Scholar
• 90 Woods K, Thomson J M, Hammond S M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.  J Biol Chem. 2007;  282 2130-2134
  PubMedGoogle Scholar
• 91 Adams J M, Cory S. Life-or-death decisions by the Bcl-2 protein family.  Trends Biochem Sci. 2001;  26 61-66
  CrossrefPubMedGoogle Scholar
• 92 Cimmino A, Calin G A, Fabbri M et al.. miR-15 and miR-16 induce apoptosis by targeting BCL2.  Proc Natl Acad Sci U S A. 2005;  102 13944-13949
  CrossrefPubMedGoogle Scholar
• 93 Smith S K. Angiogenesis and reproduction.  BJOG. 2001;  108 777-783
  PubMedGoogle Scholar
• 94 Yang W J, Yang D D, Na S et al.. Dicer is required for embryonic angiogenesis during mouse development.  J Biol Chem. 2005;  280 9330-9335
  PubMedGoogle Scholar
• 95 Suarez Y, Fernandez-Hernando C, Pober J S et al.. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.  Circ Res. 2007;  100 1164-1173
  CrossrefPubMedGoogle Scholar
• 96 Poliseno L, Tuccoli A, Mariani L et al.. MicroRNAs modulate the angiogenic properties of HUVECs.  Blood. 2006;  108 3068-3071
  CrossrefPubMedGoogle Scholar
• 97 Kuehbacher A, Urbich C, Zeiher A M et al.. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.  Circ Res. 2007;  101 59-68
  CrossrefPubMedGoogle Scholar
• 98 Chen Y, Gorski D H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5.  Blood. 2008;  111 1217-1226
  PubMedGoogle Scholar
• 99 Lee D Y, Deng Z, Wang C H et al.. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.  Proc Natl Acad Sci U S A. 2007;  104 20350-20355
  CrossrefPubMedGoogle Scholar
• 100 Chakrabarty A, Tranguch S, Daikoku T et al.. MicroRNA regulation of cyclooxygenase-2 during embryo implantation.  Proc Natl Acad Sci U S A. 2007;  104 15144-15149
  CrossrefPubMedGoogle Scholar
• 101 Fanchin R, Gallot V, Rouas-Freiss N et al.. Implication of HLA-G in human embryo implantation.  Hum Immunol. 2007;  68 259-263
  CrossrefPubMedGoogle Scholar
• 102 Giudice L C. Microarray expression profiling reveals candidate genes for human uterine receptivity.  Am J Pharmacogenomics. 2004;  4 299-312
  CrossrefPubMedGoogle Scholar
• 103 Hamatani T, Ko M S, Yamada M et al.. Global gene expression profiling of preimplantation embryos.  Hum Cell. 2006;  19 98-117
  CrossrefPubMedGoogle Scholar
• 104 Laird S M, Tuckerman E M, Li T C. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage.  Reprod Biomed Online. 2006;  13 13-23
  PubMedGoogle Scholar
• 105 Lodish H F, Zhou B, Liu G et al.. Micromanagement of the immune system by microRNAs.  Nat Rev Immunol. 2008;  8 120-130
  CrossrefPubMedGoogle Scholar
• 106 Lewis B P, Shih I H, Jones-Rhoades M W et al.. Prediction of mammalian microRNA targets.  Cell. 2003;  115 787-798
  CrossrefPubMedGoogle Scholar
• 107 Lewis B P, Burge C B, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.  Cell. 2005;  120 15-20
  CrossrefPubMedGoogle Scholar
• 108 Laschke M W, Menger M D. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis.  Hum Reprod Update. 2007;  13 331-342
  CrossrefPubMedGoogle Scholar
• 109 Calin G A, Croce C M. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.  J Clin Invest. 2007;  117 2059-2066
  CrossrefPubMedGoogle Scholar
• 110 Cho W C. OncomiRs: the discovery and progress of microRNAs in cancers.  Mol Cancer. 2007;  6 60
  CrossrefPubMedGoogle Scholar
• 111 Croce C M. Oncogenes and cancer.  N Engl J Med. 2008;  358 502-511
  CrossrefPubMedGoogle Scholar
• 112 Huppi K, Volfovsky N, Mackiewicz M et al.. MicroRNAs and genomic instability.  Semin Cancer Biol. 2007;  17 65-73
  CrossrefPubMedGoogle Scholar
• 113 Ma L, Teruya-Feldstein J, Weinberg R A. MicroRNAs in malignant progression.  Cell Cycle. 2008;  7 570-572
  PubMedGoogle Scholar
• 114 Rajalingam K, Schreck R, Rapp U R et al.. Ras oncogenes and their downstream targets.  Biochim Biophys Acta. 2007;  1773 1177-1195
  PubMedGoogle Scholar
• 115 Sen C K, Roy S. miRNA: licensed to kill the messenger.  DNA Cell Biol. 2007;  26 193-194
  CrossrefPubMedGoogle Scholar
• 116 Wu W, Sun M, Zou G M et al.. MicroRNA and cancer: current status and prospective.  Int J Cancer. 2007;  120 953-960
  CrossrefPubMedGoogle Scholar
• 117 Chang T C, Yu D, Lee Y S et al.. Widespread microRNA repression by Myc contributes to tumorigenesis.  Nat Genet. 2008;  40 43-50
  PubMedGoogle Scholar
• 118 McAvoy S, Ganapathiraju S C, Ducharme-Smith A L et al.. Non-random inactivation of large common fragile site genes in different cancers.  Cytogenet Genome Res. 2007;  118 260-269
  CrossrefPubMedGoogle Scholar
• 119 Jones R L, Findlay J K, Farnworth P G et al.. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion.  Endocrinology. 2006;  147 724-732
  PubMedGoogle Scholar
• 120 Esquela-Kerscher A, Trang P, Wiggins J F et al.. The let-7 microRNA reduces tumor growth in mouse models of lung cancer.  Cell Cycle. 2008;  7 759-764
  CrossrefPubMedGoogle Scholar
• 121 Johnson C D, Esquela-Kerscher A, Stefani G et al.. The let-7 microRNA represses cell proliferation pathways in human cells.  Cancer Res. 2007;  67 7713-7722
  CrossrefPubMedGoogle Scholar
• 122 Lee Y S, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.  Genes Dev. 2007;  21 1025-1030
  Google Scholar
• 123 Calin G A, Ferracin M, Cimmino A et al.. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.  N Engl J Med. 2005;  353 1793-1801
  CrossrefPubMedGoogle Scholar
• 124 Bircan S, Ensari A, Ozturk S et al.. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.  Pathol Oncol Res. 2005;  11 32-39
  CrossrefPubMedGoogle Scholar
• 125 Rinaldi A, Poretti G, Kwee I et al.. Concomitant MYC and microRNA cluster miR-17–92 (C13orf25) amplification in human mantle cell lymphoma.  Leuk Lymphoma. 2007;  48 410-412
  CrossrefPubMedGoogle Scholar
• 126 Lu Y, Thomson J M, Wong H Y et al.. Transgenic over-expression of the microRNA miR-17–92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.  Dev Biol. 2007;  310 442-453
  CrossrefPubMedGoogle Scholar
• 127 le Sage C, Nagel R, Egan D A et al.. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation.  EMBO J. 2007;  26 3699-3708
  CrossrefPubMedGoogle Scholar
• 128 Kim H K, Lee Y S, Sivaprasad U et al.. Muscle-specific microRNA miR-206 promotes muscle differentiation.  J Cell Biol. 2006;  174 677-687
  CrossrefPubMedGoogle Scholar
• 129 Adams B D, Furneaux H, White B A. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.  Mol Endocrinol. 2007;  21 1132-1147
  CrossrefPubMedGoogle Scholar
• 130 Singh M, Zaino R J, Filiaci V J et al.. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.  Gynecol Oncol. 2007;  106 325-333
  CrossrefPubMedGoogle Scholar
• 131 Bukulmez O, Hardy D B, Carr B R et al.. Inflammatory status influences aromatase and steroid receptor expression in endometriosis.  Endocrinology. 2008;  149 1190-1204
  CrossrefPubMedGoogle Scholar
• 132 Gleeson N C, Gonsalves R, Bonnar J. Plasminogen activator inhibitors in endometrial adenocarcinoma.  Cancer. 1993;  72 1670-1672
  CrossrefPubMedGoogle Scholar
• 133 Lim L P, Glasner M E, Yekta S et al.. Vertebrate microRNA genes.  Science. 2003;  299 1540
  CrossrefPubMedGoogle Scholar
• 134 Boren T, Xiong Y, Hakam A et al.. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.  Gynecol Oncol. 2008;  110 206-215
  CrossrefPubMedGoogle Scholar
• 135 Daikoku T, Hirota Y, Tranguch S et al.. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.  Cancer Res. 2008;  68 5619-5627
  CrossrefPubMedGoogle Scholar
• 136 Hong X, Luense L J, McGinnis L K, Nothnick W B, Christenson L K. Dicer1 is essential for female fertility and normal development of the female reproductive system.  Endocrinology. 2008;  , Aug 14 [Epub ahead of print]
  PubMedGoogle Scholar
• 137 Nagaraja A K, Andreu-Vieyra C, Franco H L et al.. Deletion of dicer in somatic cells of the female reproductive tract causes sterility.  Mol Endocrinol. 2008;  22 2336-2352
  CrossrefPubMedGoogle Scholar
• 138 Hu S J, Ren G, Liu J L et al.. MicroRNA expression and regulation in mouse uterus during embryo implantation.  J Biol Chem. 2008;  283 23473-23484
  CrossrefPubMedGoogle Scholar

Nasser CheginiPh.D. 

Department of Obstetrics and Gynecology, University of Florida

Gainesville, FL 32610

Email: cheginin@obgyn.ufl.edu